Strategic Partnerships Olink has active and high-profile collaboration activity with industry leaders like Regeneron and Evotec, indicating receptiveness to co-development and translational biomarker projects that can be expanded with targeted proteomics panels.

Expansion Opportunities Acquisitions and potential integration signals around large players (e.g., Thermo Fisher/Fishersci interest) suggest a market environment open to scale, providing openings to propose broader platform adoption, service bundling, or channel partnerships with distributors.

High Value Customers With revenue in the mid-range and notable investor relations activity, there is upside in targeting biotech and pharma R&D teams pursuing large population studies and translational research that leverage Olink’s validated, scalable proteomics data.

Data Infrastructure Olink’s tech stack emphasizes data quality and integration (validated datasets, scalable data platforms) making it suitable to offer adjacent data analytics, cloud-based workspaces, and integration services with existing lab workflows for faster decision-making.

Global Reach Based in Sweden with multinational collaborations, there is potential to expand sales through regional partnerships, international CROs, and cross-border studies, especially in markets prioritizing translational proteomics and population-scale research.